Korean Journal of Ophthalmology

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity

Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han

Korean J Ophthalmol. 2019;33(3):272-278. Published online June 4, 2019
DOI: https://doi.org/10.3341/kjo.2019.0011

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity

Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han

Korean Journal of Ophthalmology. 2019;33(3):272

Link1 Link2 Link3

Delayed Laser photocoagulation following intravitreal anti–vascular endothelial growth factor injection allows immature retinal vessels to regrow without recurrence of retinopathy of prematurity

Ki Yup Nam, Ji Eun Lee, Joo Eun Lee, Hyun Wong Kim, Sang Joon Lee

. 2019;

Link1 Link2

Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis

William B. Yates, Zaid Mammo, Matthew P Simunovic

Canadian Journal of Ophthalmology. 2021;56(6):355-363

Link1 Link2

Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti–Vascular Endothelial Growth Factor

Gerard P. Barry, Yinxi Yu, Gui-Shuang Ying, Lauren A. Tomlinson, Juliann Lajoie, Marilyn Fisher, Gil Binenbaum

Ophthalmology. 2021;128(8):1188-1196

Link1 Link2

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity

Christopher K. Hwang, G. Baker Hubbard, Amy K. Hutchinson, Scott R. Lambert

Ophthalmology. 2015;122(5):1008-1015

Link1 Link2

Short-term risk of retinal detachment following treatment of retinopathy of prematurity with laser photocoagulation versus intravitreal anti-vascular endothelial growth factor

Gerard P. Barry, Yinxi Yu, Gui-shuang Ying, Lauren A. Tomlinson, Juliann Lajoie, Marilyn Fisher, Gil Binenbaum

Journal of American Association for Pediatric Ophthalmology and Strabismus. 2021;25(4):e2

Link1 Link2

Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis

Qihang Kong, Wai-kit Ming, Xue-Song Mi

BMJ Open. 2021;11(2):e042384

Link1

Treatment for non-type 1 retinopathy of prematurity by intravitreal injection of anti-vascular endothelial growth factor drugs

Haitao Zhang, Xin Yang, Fangfang Zheng, Xiangke Yin, Suhua Wan, Yingying Xu

. 2022;

Link1 Link2

Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes

Marko M. Popovic, Prem Nichani, Rajeev H. Muni, Kamiar Mireskandari, Nasrin N. Tehrani, Peter J. Kertes

Survey of Ophthalmology. 2021;66(4):572-584

Link1 Link2

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity

Seung Hee Jeon, Young-Jung Roh

American Journal of Ophthalmology Case Reports. 2021;22:101097

Link1 Link2